分離済み変異体

tm3816

Allele Nametm3816
BalanceNot Required
OutCrossNot Accepted
Sequence NameC33C12.3
Gene NameC33C12.3
Worm BaseAllele Name tm3816
Gene Name C33C12.3
Sequence C33C12.3
Phenotype Information from the receiver is posted in the form of a "researcher : phenotype" homozygous viable.
Mutation site Please see gene structure to locate the deletion in relation to exon(s) 19653/19654-20182/20183 (529 bp deletion)
ChromosomeII
Putative gene structurejoin(16301..16355, 16406..16488, 17091..17196, 17390..17542, 17890..18023, 18072..18144, 18711..18807, 18857..19097, 19626..19757, 19808..19894, 20024..20187, 20944..21070, 21120..21239)
Map position-13.84
Balancer
Map position of balancer
Sequence of primersIntFwd:GAAAGCCCAAGGCTACGTTA,ExtFwd:CCGCACCGCATGCCACAAAT,IntRev:TGCGGTGTTTTGGGGTACTG,ExtRev:AGTTCGGTGTTTTGGGGTAC
Distributed lab
DepositorDr. S. Mitani
References Please submit your publication
Liu N, Li R, Huang X, Lakso M, Wong G.
The C. elegans gba-3 gene encodes a glucocerebrosidase that exacerbates α-synuclein-mediated impairments in deletion mutants.
Transl Neurodegener 2025 14(1) 9 
[ PubMed ID = 39940047 ] [ RRC reference ]

Hao L, Ben-David O, Babb SM, Futerman AH, Cohen BM, Buttner EA.
Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.
Neuropsychopharmacology 2017 42(4) 951-962 
[ PubMed ID = 27711049 ] [ RRC reference ]